Besides, we report a mechanism by which NV669 decreases the proliferation of pancreatic and hepatic cancer cells likely through the inhibition of PTP1B activity, resulting in the modification of cell-to-cell contact and cell adherence ending with cell detachment and apoptosis. Here, PTPN1 is linked to liver cancer.